Packets of molecular cargo called extracellular vesicles (EVs) can be isolated from the blood of people with cystic fibrosis…
Articles by Marisa Wexler, MS
A new company, Inspire Biotherapeutics, has launched with the goal of developing a new gene therapy platform that could…
AR-501, an experimental, nonantibiotic inhaled treatment for chronic lung infections in cystic fibrosis (CF), was well tolerated among adults…
The IRT test, commonly used for screening newborn for cystic fibrosis (CF), is most accurate when performed between…
A Phase 3 clinical trial called COPILOT, which will test the antibiotic ColiFin (inhaled colistimethate sodium) in people with…
BreatheCon 2023 — the seventh annual virtual gathering offering online support for adults with cystic fibrosis (CF) — is…
Among children with cystic fibrosis (CF), bone health tends to become worse with older age — and poor bone…
Having cystic fibrosis (CF) can put a tremendous financial strain on patients: In the U.K., the typical family affected…
The Cystic Fibrosis Foundation is investing up to $15 million in ReCode Therapeutics to support the development of…
A novel inhaled antibiotic that Spexis is developing to treat infections of Pseudomonas aeruginosa — the key bacterial agent of lung…